Seismic Therapeutic
Daniela Cipolletta has a diverse background in immunology and molecular medicine, with experience working at various companies and institutions. Daniela has contributed significantly to projects related to immuno-oncology, autoimmunity, and metabolic diseases. Daniela has held roles ranging from Scientist to Senior Director, showcasing their expertise in identifying novel targets and mechanisms in the field. Their education includes a Ph.D. in Molecular Medicine and Immunology from Harvard University, further solidifying their knowledge and skills in the industry.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.